Gaudium IVF and Women Health Limited — PPTs, 14-08-2026: Investor Presentation

Here's a summary of Gaudium IVF's Q1 FY27 performance and strategic outlook, tailored for retail investors:

**1. Business Performance:**

Gaudium IVF saw a consolidated revenue growth of 9.13% YoY to Rs. 1,937.66 lakh in Q1 FY27. While overall performance faced moderation due to investments in expansion and technology, the company is strategically positioning itself for future growth.

**2. Growth Drivers or Strategy:**

The company is heavily investing in its AI-powered solutions, SiD and ERICA, for sperm and embryo selection, which are expected to enhance success rates. Expansion plans include launching new hubs in Delhi/NCR and Nagpur, with further centers planned, aiming to boost pan-India brand visibility and customer footfall.

**3. Recent Developments:**

The focus has been on integrating AI tools SiD and ERICA and undertaking expansion-related costs, including new hub setups and clinical hiring, as part of their planned rollout for FY27.

**4. Key Financial Metrics:**

Consolidated Revenue from Operations stood at Rs. 1,937.66 lakh, up 9.13% YoY. Adjusted EBITDA was Rs. 532.75 lakh with a margin of 27.49%.

**5. Management Commentary / Outlook:**

Gaudium IVF is committed to a rapid growth strategy with planned new center launches to enhance its presence and drive higher revenues. These investments are expected to support future growth as new centers scale up.